Simplicity Wealth’s Anixa Biosciences ANIX Stock Holding History

Simplicity Wealth’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.6K	Hold	12,000	–	–	﹤0.01%	1011
2026 Q1	$31K	Hold	12,000	–	–	﹤0.01%	739
2025 Q4	$37.4K	Sell	12,000 -1,969	-14%	-$8.06K	﹤0.01%	690
2025 Q3	$46.1K	Hold	13,969	–	–	﹤0.01%	696
2025 Q2	$46.1K	Hold	13,969	–	–	﹤0.01%	581
2025 Q1	$40K	Hold	13,969	–	–	﹤0.01%	548
2024 Q4	$32.4K	Hold	13,969	–	–	0.01%	323
2024 Q3	$44K	Hold	13,969	–	–	﹤0.01%	494
2024 Q2	$30.9K	Hold	13,969	–	–	﹤0.01%	1221
2024 Q1	$43.6K	Buy	+13,969	New	+$55.7K	﹤0.01%	1154

Other funds holding ANIX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Simplicity Wealth's ANIX Position: Q2 2026 in Review

Simplicity Wealth held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 12,000 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

Simplicity Wealth first reported a position in ANIX in Q1 2024 and has held it in 10 quarters since. The position peaked at $46.1K in Q3 2025. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

Simplicity Wealth held 12,000 shares of Anixa Biosciences worth $33.6K as of Q2 2026.
Simplicity Wealth left its Anixa Biosciences share count unchanged in Q2 2026.
Anixa Biosciences made up ﹤0.01% of Simplicity Wealth's portfolio in Q2 2026, its #1011 holding.
Simplicity Wealth first reported a position in Anixa Biosciences in Q1 2024 and has held it in 10 quarters since.
Simplicity Wealth's Anixa Biosciences position peaked at $46.1K in Q3 2025.
62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.